Antibiotic Resistance in : Challenges in Research and Treatment

Overview

Journal Microorganisms

Specialty Microbiology

Date 2022 Sep 23

PMID 36144300

Authors

Boris Shaskolskiy

Ilya Kandinov

Ekaterina Dementieva

Dmitry Gryadunov

Affiliations

Soon will be listed here.

Abstract

Gonococcal infection caused by the Gram-negative bacteria is one of the most common sexually transmitted infections (STIs) worldwide [...].

Citing Articles

Oxydifficidin, a potent antibiotic due to DedA assisted uptake and ribosomal protein RplL sensitivity.

Kan J, Morales A, Hernandez Y, Ternei M, Lemetre C, Maclntyre L bioRxiv. 2024; .

PMID: 38854004 PMC: 11160649. DOI: 10.1101/2024.05.27.596031.

Emerging threat of antimicrobial resistance in Neisseria gonorrhoeae: pathogenesis, treatment challenges, and potential for vaccine development.

Omeershffudin U, Kumar S Arch Microbiol. 2023; 205(10):330.

PMID: 37688619 DOI: 10.1007/s00203-023-03663-0.

Gonococcal Genetic Island in the Global Population: A Model of Genetic Diversity and Association with Resistance to Antimicrobials.

Kravtsov D, Gryadunov D, Shaskolskiy B Microorganisms. 2023; 11(6).

PMID: 37375049 PMC: 10301925. DOI: 10.3390/microorganisms11061547.

Azithromycin Susceptibility Testing and Molecular Investigation of Isolates Collected in Russia, 2020-2021.

Kandinov I, Shaskolskiy B, Kravtsov D, Vinokurova A, Gorshkova S, Kubanov A Antibiotics (Basel). 2023; 12(1).

PMID: 36671371 PMC: 9854565. DOI: 10.3390/antibiotics12010170.

Global status of Azithromycin and Erythromycin Resistance Rates in : A Systematic Review and Meta-analysis.

Lu Z, Tadi D, Fu J, Azizian K, Kouhsari E Yale J Biol Med. 2022; 95(4):465-478.

PMID: 36568835 PMC: 9765340.

References

Day M, Jacobsson S, Spiteri G, Kulishev C, Sajedi N, Woodford N . Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019. BMC Infect Dis. 2022; 22(1):524. PMC: 9171984. DOI: 10.1186/s12879-022-07509-w. View

Ladhani S, Lucidarme J, Parikh S, Campbell H, Borrow R, Ramsay M . Meningococcal disease and sexual transmission: urogenital and anorectal infections and invasive disease due to Neisseria meningitidis. Lancet. 2020; 395(10240):1865-1877. DOI: 10.1016/S0140-6736(20)30913-2. View

Petousis-Harris H, Paynter J, Morgan J, Saxton P, McArdle B, Goodyear-Smith F . Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study. Lancet. 2017; 390(10102):1603-1610. DOI: 10.1016/S0140-6736(17)31449-6. View

Bolton M, van der Straten A, Cohen C . Probiotics: potential to prevent HIV and sexually transmitted infections in women. Sex Transm Dis. 2008; 35(3):214-25. DOI: 10.1097/OLQ.0b013e31815b017a. View

Unemo M, Jensen J . Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium. Nat Rev Urol. 2017; 14(3):139-152. DOI: 10.1038/nrurol.2016.268. View

Semchenko E, Day C, Seib K . The Vaccine Candidate NHBA Elicits Antibodies That Are Bactericidal, Opsonophagocytic and That Reduce Gonococcal Adherence to Epithelial Cells. Vaccines (Basel). 2020; 8(2). PMC: 7349534. DOI: 10.3390/vaccines8020219. View

Zhao L, Liu A, Li R, Zhang Z, Jia Y, Zhao S . High prevalence of blaTEM-135 and genetic epidemiology of blaTEM-135-carrying Neisseria gonorrhoeae isolates in Shandong, China, 2017-19. J Antimicrob Chemother. 2022; 77(9):2406-2413. DOI: 10.1093/jac/dkac192. View

Barbee L, St Cyr S . Management of Neisseria gonorrhoeae in the United States: Summary of Evidence From the Development of the 2020 Gonorrhea Treatment Recommendations and the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infection Treatment.... Clin Infect Dis. 2022; 74(Suppl_2):S95-S111. DOI: 10.1093/cid/ciac043. View

Sanchez-Buso L, Cole M, Spiteri G, Day M, Jacobsson S, Golparian D . Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance study. Lancet Microbe. 2022; 3(6):e452-e463. DOI: 10.1016/S2666-5247(22)00044-1. View

10.

Allan-Blitz L, Adamson P, Klausner J . Resistance-Guided Therapy for Neisseria gonorrhoeae. Clin Infect Dis. 2022; 75(9):1655-1660. PMC: 10200317. DOI: 10.1093/cid/ciac371. View

11.

Mlynarczyk-Bonikowska B, Majewska A, Malejczyk M, Mlynarczyk G, Majewski S . Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century. Med Microbiol Immunol. 2019; 209(2):95-108. PMC: 7125254. DOI: 10.1007/s00430-019-00651-4. View

12.

Maurakis S, Cornelissen C . Recent Progress Towards a Gonococcal Vaccine. Front Cell Infect Microbiol. 2022; 12:881392. PMC: 9038166. DOI: 10.3389/fcimb.2022.881392. View

13.

Ohnishi M, Saika T, Hoshina S, Iwasaku K, Nakayama S, Watanabe H . Ceftriaxone-resistant Neisseria gonorrhoeae, Japan. Emerg Infect Dis. 2011; 17(1):148-9. PMC: 3204624. DOI: 10.3201/eid1701.100397. View

14.

Shaskolskiy B, Kandinov I, Kravtsov D, Filippova M, Chestkov A, Solomka V . Prediction of ceftriaxone MIC in Neisseria gonorrhoeae using DNA microarray technology and regression analysis. J Antimicrob Chemother. 2021; 76(12):3151-3158. DOI: 10.1093/jac/dkab308. View

15.

Zhou Q, Liu J, Chen S, Xu W, Han Y, Yin Y . The Accuracy of Molecular Detection Targeting the Mutation C2611T for Detecting Moderate-Level Azithromycin Resistance in : A Systematic Review and Meta-Analysis. Antibiotics (Basel). 2021; 10(9). PMC: 8471969. DOI: 10.3390/antibiotics10091027. View

16.

Zapun A, Morlot C, Taha M . Resistance to β-Lactams in Neisseria ssp Due to Chromosomally Encoded Penicillin-Binding Proteins. Antibiotics (Basel). 2016; 5(4). PMC: 5187516. DOI: 10.3390/antibiotics5040035. View

17.

Retchless A, Kretz C, Chang H, Bazan J, Abrams A, Norris Turner A . Expansion of a urethritis-associated Neisseria meningitidis clade in the United States with concurrent acquisition of N. gonorrhoeae alleles. BMC Genomics. 2018; 19(1):176. PMC: 5834837. DOI: 10.1186/s12864-018-4560-x. View

18.

Taylor S, Morris D, Avery A, Workowski K, Batteiger B, Tiffany C . Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea: A Phase 2, Randomized, Dose-Ranging, Single-Oral Dose Evaluation. Clin Infect Dis. 2018; 67(4):504-512. PMC: 6070052. DOI: 10.1093/cid/ciy145. View

19.

St Cyr S, Barbee L, Workowski K, Bachmann L, Pham C, Schlanger K . Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(50):1911-1916. PMC: 7745960. DOI: 10.15585/mmwr.mm6950a6. View

20.

Lin X, Qin X, Wu X, Liao Y, Yu Y, Xie Q . Markedly Increasing Antibiotic Resistance and Dual Treatment of Neisseria gonorrhoeae Isolates in Guangdong, China, from 2013 to 2020. Antimicrob Agents Chemother. 2022; 66(4):e0229421. PMC: 9017359. DOI: 10.1128/aac.02294-21. View